← Open Payments lookup

ANDRANIK AVAKIAN: Open Payments

NPI 1528599982 · CLOVIS, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,466 in 158 payments from 16 companies in 2025. Trend: 2023 $1,578 · 2024 $1,969 · 2025 $2,466

Food & beverage: $2,466
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.33$478
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)32$466
ABBVIE INC.30$246
Alkermes, Inc.13$234
Lundbeck LLC7$215
Axsome Therapeutics, Inc.14$213
Teva Pharmaceuticals USA, Inc.6$135
Vanda Pharmaceuticals Inc.5$117
Supernus Pharmaceuticals, Inc.4$88
E.R. Squibb & Sons, L.L.C.3$70

Products named: REXULTI, CAPLYTA, VRAYLAR, ARISTADA, Auvelity, AUSTEDO XR, Qelbree, COBENFY.

Industry payments across CA — which companies pay providers there.